Lokatial
Helix TherapeuticsActive session
Transparency Reporting · Q2 2026 cycle

One reporting cycle. Every transfer of value. Every framework.

Emsah pulls every transfer of value from your connected CRM, ERP, HR, content, and contract systems, de-dupes against the audit ledger, applies the framework-specific rules, and produces a draft submission for compliance review - before anything reaches CMS Open Payments or your EFPIA member association.

Next deadline: 31 Mar 2027 Source-of-truth: Lokatial audit ledgerGenerated by Lokatial AI· Emsah · Transparency Agent
Active framework
US Sunshine Act (Open Payments)
Regulator: CMS
Submission window
31 Mar 2027
318 recipients · $1.42M reportable
Required fields (6)
Covered recipient NPINature of paymentDate of paymentRelated covered productForm of paymentThird-party recipient indicator
Pre-flight
Emsah verified the draft against all framework rules.
  • Schema validates against CMS template
  • All amounts normalised to reporting currency
  • Audit ledger hash sealed for 12+ source decisions
  • 11 exceptions awaiting reviewer disposition
How Emsah collates this
Source systems → Transparency agent → Draft report
Generated by Lokatial AI· Emsah · Transparency Agent· live
Veeva Vault CRM
HCP engagements, meals, speaker programs
412 records
SAP S/4HANA · Joule
Honoraria postings, travel reimbursements
287 records
Workday Illuminate
Employee ToV attributions
54 records
Veeva PromoMats
Content & sample distributions
193 records
SFTP / CSV (CRO)
Investigator grants & milestone fees
38 records
Agent
Emsah
Transparency reporting
1,847 transfers · de-duped · FMV-validated
Draft Report
Framework-specific schema · 100% coverage · sealed with audit hash
Helix Therapeutics
Total ToVs aggregated
1,847
Across 5 source systems
Unique HCP recipients
612
454 individual · 158 institutional
Total reportable value
€2.41M
Normalised to EUR
Exceptions flagged
11
1 blocker · 4 review · 6 info
Draft submission
Sunshine Act Q2 2026 — Helix Therapeutics
Generated by Emsah · 31 May 2026 · v0.4 draft
Awaiting reviewer sign-off
RecipientIdentifierCategory / NatureAmountDateProductSource
Dr. Maria SchmidtEFPIA-IDDE-EFPIA-441290
Speaker fee
Advisory board honorarium
€11,400.002026-05-12Helixir-XRVeeva Vault CRM
Dr. James OkaforNPI1942765538
Travel & lodging
Congress travel reimbursement
$3,820.552026-04-22Helixir-XRSAP S/4HANA · Joule
Cleveland Clinic FoundationNPI1962404449
Research grant
Investigator-initiated study (Phase IV)
$184,000.002026-04-01VeriquelSFTP / CSV (CRO)
Dr. Sofía NavarroEFPIA-IDES-EFPIA-220914
Consulting fee
Medical advisory consultation
€4,200.002026-05-28Helixir-XRVeeva Vault CRM
Dr. Henri LefèvreRPPS10004421558
Meal
Educational dinner (8 attendees)
€612.402026-05-04VeriquelSAP S/4HANA · Joule
Dr. Priya RamanNPI1730288841
Speaker fee
CME-accredited lecture
$6,500.002026-05-19VeriquelVeeva PromoMats
Dr. Lukas BergerEFPIA-IDDE-EFPIA-119870
Sample / drug
Clinician sample distribution
€280.002026-05-09Helixir-XRVeeva PromoMats
Mass General BrighamNPI1518963370
Charitable contribution
Patient education grant
$25,000.002026-04-18Workday Illuminate
Showing 8 of 1,847 rows — full report contains 100% coverage.SHA-256 · 9f4c…a2e1
Exception queue
Reviewer attention required
Flagged by Emsah before submission. Each item traces back to its source decision.
  • Dr. Maria Schmidt — €11,400 speaker fee exceeds €10,000 EFPIA detailed-disclosure threshold
    Triggers individual disclosure regardless of consent withdrawal. Confirm category mapping before submission.
  • Dr. Kenji Tanaka — JP individual-disclosure consent not on file
    JPMA guideline requires explicit consent for named disclosure. Currently falls back to institution-level aggregation.
  • Cleveland Clinic IDN — 3 ToVs missing NPI on receiving sub-entity
    Parent NPI present, but Open Payments requires the receiving covered recipient identifier.
  • Reimbursement RB-22019 — currency conversion fell back to monthly average
    Live FX feed timed out; daily ECB rate used as fallback. Difference: €14.20.
  • Speaker program SP-441 — content version superseded after event
    Materials presented were MLR-approved at event time; current PromoMats version differs. Audit trail preserved.
0 of 2 reviewer signatures captured
Required: J. Okonkwo (Compliance Lead) · S. Park (Medical Director)